References
- Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanoma (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87–97.
- Morton RL, Howard K, Thompson JF. The cost-effectivess of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma. Ann Surg Oncol 2009;16:929–40.
- Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma accuracy and morbidity in MSLT-1, an international multicentre trial. Ann Surg 2005;242:302–11.
- Bostick P, Essner R, Sarantou T, et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am J Surg 1997;174:536–9.
- Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.
- Chakera AH, Lock-Andersen J, Hesse U, et al. One-day or two-day procedure for sentinel node biopsy in melanoma? Eur J Nucl Med Mol Imaging 2009;36:928–37.
- DMG kirurgi. [Cited 2013 Sept 5]; Available from: http://www.melanoma.dk/. 2003.
- Riber-Hansen R, Hastrup N, Clemmesen O, et al. Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: a national multicentre study. Eur J Cancer 2012;48:347–52.
- Interaktiv DRG. [Updated 2013 May 16; cited 2013 Nov 15]; Available from: http://drgservice.ssi.dk/grouper/Modules/Home/. 2013.
- Nielsen KR, Chakera AH, Hesse B, et al. The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients. Eur J Nucl Med Mol Imaging 2011;38:1999–2004.
- Morton DL, Bostick PJ. Will the true sentinel node please stand? Ann Surg Oncol 1999;11:188–94.
- Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphis agents in patients with cutaneous melanoma. J Nucl Med 1998;39:1185–90.
- Chen YW, Chuang YW, Lai YC, et al. Is early dynamic lymphoscintigraphy for detection of sentinel lymph nodes always achievable in breast tumor? Ann Nucl Med 2006;20:45–50.
- Doting MH, Stiekema HM, de Vries J, et al. Immediate dynamic lymphoscintigraphy delivers no additional value to lymphoscintigraphy 3 hours after tracer injection in sentinel node biopsy in breast cancer patients. J Surg Oncol 2007;95:469–75.
- Sadeghi R, Forghani MN, Memar B, et al. Comparison of early and delayed lymphoscintigraphy images of early breast cancer patients undergoing sentinel node mapping. Nucl Med Commun 2010;31:521–5.
- Chakera AH, Hesse B, Burak Z, et al. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 2009;36:1713–42.
- Morton DL. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 2012;29:699–706.
- Roaten JB, Pearlman N, Gonzalez R, McCarter MD. Identifying risk factors for complications following sentinel lymph node biopsy for melanoma. Arch Surg 2005;140:85–9.
- Darren N, Hutchinson S, Pohl M, Powell B. Sentinel lymph node biopsy for malignant melanoma as day surgery. J Plast Reconstr Aesthet Surg 2007;60:631–4.